GH
Guardant Health Inc
Halal Rating :
Last Price
$36.63
Last updated:
Market Cap
-
7D Change
-3.86%
1 Year Change
57.75%
Company Overview
Industries
Exchange
Next Earnings Date
Guardant Health Inc is a precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets, and advanced analytics. The company offers liquid biopsy tests for advanced stage cancer and minimal residual disease detection. Their products include Guardant360 CDx and Guardant360 Response tests for advanced-stage cancer patients, Shield test for colorectal cancer screening, and Reveal tests for detecting residual disease.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $191.48m | $308.8m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $177.24m | $277.85m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $168.49m | $268.82m | - | $645000.0 | 0.00% | 0.24% |
Company Impact
Help us evaluate Guardant Health Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.